Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

GSK Announces Fourth Quarter 2012 Results and 2013 Plans

Feb 7, 2013

Group sales were down, but R&D progress points to future growth.

US Pharmacopeial Convention Announces Revised Official Dates for Elemental Impurities Chapters

Jan 31, 2013

Two general chapters on elemental impurities? limits and procedures are to become official Feb. 1, 2013, with implementation proposed for May 1, 2014.

Rutgers University Research Center and Janssen Develop Continuous Manufacturing Process

Jan 17, 2013

Rutgers engineers constructed a direct compaction line in collaboration with Janssen.

Using Micronization to Reduce API Particle Size

Micronization can be performed with a jet mill or bead mill.
Jan 16, 2013

Micronization can be performed with a jet mill or bead mill.

Eli Lilly Announces 2013 Financial Guidance

Jan 8, 2013

Eli Lilly expects overall revenue growth in the coming year.

MIT Develops Durable Injectable Gels

Dec 28, 2012

Chemical engineers at the Massachusetts Institute of Technology (MIT) have designed an injectable gel with improved durability for use in drug delivery.

University of Connecticut Studies Drug-Carrying Nanoparticles

Dec 28, 2012

A University of Connecticut chemical engineering professor received a National Science Foundation grant to study how nanoparticles flow in the bloodstream, which is crucial for their use in drug delivery.

Plastic Shows Benefits in Parenteral Packaging

Plastic is finding increased use in vials and syringes as concerns about glass breakage and delamination and desire for increased functionality lead pharmaceutical companies to consider alternatives.
Dec 19, 2012

Plastic is finding increased use in vials and syringes as concerns about glass breakage and delamination and desire for increased functionality lead pharmaceutical companies to consider alternatives.

US Supreme Court to Hear Pay-for-Delay Case

Dec 11, 2012

The US Supreme Court accepted an appeal by the Federal Trade Commission of a decision that upheld an arrangement of payments by Solvay Pharmaceuticals to generic drug companies to postpone introduction of generic versions of its branded testosterone-replacement drug.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here